Form 4: Oruka COO Sells Shares for Tax Obligations

Oruka Therapeutics' Chief Operating Officer, Laura Lee Sandler, sold 600 shares of common stock to cover tax withholding obligations related to restricted stock unit vesting.

Summary

• Laura Lee Sandler, Chief Operating Officer and Director of Oruka Therapeutics, Inc. (ORKA), reported a sale of common stock.
• The transaction involved the disposition of 600 shares of common stock at a price of $41.3 per share.
• The total value of the shares sold was $24,780 (600 shares * $41.3/share).
• The sale was executed on March 16, 2026.
• The purpose of the sale was to satisfy tax withholding obligations arising from the vesting of restricted stock units, as part of Oruka Therapeutics, Inc.'s automatic, non-discretionary, sell-to-cover procedure.
• Following this transaction, Laura Lee Sandler beneficially owns 236,984 shares of Oruka Therapeutics, Inc. common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. The sale is a non-discretionary, automatic transaction to cover tax liabilities from RSU vesting, which is a standard practice for executive compensation and does not indicate a change in company fundamentals or management sentiment.

Future Outlook

The filing does not contain any forward-looking statements or guidance.

Industry Context

StockSavvy.ai notes that sell-to-cover transactions for tax obligations are a common and routine occurrence for executives receiving equity compensation, particularly restricted stock units (RSUs). These sales are typically non-discretionary and do not reflect a change in management's outlook on the company's prospects, distinguishing them from open market discretionary sales.

Comparison to Industry Standards

• N/A. This Form 4 reports a routine insider transaction for tax purposes, which does not lend itself to direct comparison with industry-specific operational or financial benchmarks.

Stakeholder Impact

• Minimal impact on shareholders, as this is a routine, non-discretionary sale for tax purposes and not indicative of a change in company performance or management's view.

Key Dates

Keywords

Oruka Therapeutics, ORKA, Insider Trading, Form 4, Laura Lee Sandler, Chief Operating Officer, Stock Sale, Tax Withholding, Restricted Stock Units, Equity Compensation